Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Depreciation & Amortization (IS) (2016 - 2019)

Historic Depreciation & Amortization (IS) for Xtant Medical Holdings (XTNT) over the last 11 years, with Q3 2019 value amounting to $137000.0.

  • Xtant Medical Holdings' Depreciation & Amortization (IS) fell 8668.61% to $137000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $1.5 million, marking a year-over-year decrease of 6663.67%. This contributed to the annual value of $4.1 million for FY2018, which is 5102.63% down from last year.
  • Per Xtant Medical Holdings' latest filing, its Depreciation & Amortization (IS) stood at $137000.0 for Q3 2019, which was down 8668.61% from $146000.0 recorded in Q2 2019.
  • Over the past 5 years, Xtant Medical Holdings' Depreciation & Amortization (IS) peaked at $2.1 million during Q4 2015, and registered a low of $100663.0 during Q2 2015.
  • Moreover, its 5-year median value for Depreciation & Amortization (IS) was $1.2 million (2016), whereas its average is $989765.5.
  • In the last 5 years, Xtant Medical Holdings' Depreciation & Amortization (IS) soared by 360651.39% in 2015 and then tumbled by 8668.61% in 2019.
  • Xtant Medical Holdings' Depreciation & Amortization (IS) (Quarter) stood at $2.1 million in 2015, then tumbled by 39.11% to $1.3 million in 2016, then grew by 10.36% to $1.4 million in 2017, then dropped by 24.35% to $1.0 million in 2018, then tumbled by 86.88% to $137000.0 in 2019.
  • Its Depreciation & Amortization (IS) stands at $137000.0 for Q3 2019, versus $146000.0 for Q2 2019 and $159000.0 for Q1 2019.